Liven Pharmaceuticals Cash Flow Statement

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2015 - 2019
Net Income	113.64	-11.18	-12.33	-14.29	-14.63	-16.93	Upgrade
Depreciation & Amortization	15.93	11.79	13.1	14.56	16.08	17.87	Upgrade
Other Operating Activities	-46.44	-2.61	-2.9	-3.22	-3.55	-3.09	Upgrade
Change in Accounts Payable	-1.25	-	-	-0.07	-4.16	-	Upgrade
Change in Other Net Operating Assets	1.12	1.12	-0.14	0.76	-0.52	0.26	Upgrade
Operating Cash Flow	-19.81	-0.88	-2.27	-2.26	-6.79	-1.89	Upgrade
Short-Term Debt Issued	-	0.89	2.27	2.24	6.79	1.91	Upgrade
Total Debt Issued	11.56	0.89	2.27	2.24	6.79	1.91	Upgrade
Net Debt Issued (Repaid)	-193.08	0.89	2.27	2.24	6.79	1.91	Upgrade
Financing Cash Flow	-193.08	0.89	2.27	2.24	6.79	1.91	Upgrade
Net Cash Flow	8.9	0.01	0	-0.02	-0.01	0.03	Upgrade
Levered Free Cash Flow	-213.17	4.29	3.45	4.31	0.03	9.85	Upgrade
Unlevered Free Cash Flow	-213.17	4.29	3.45	4.31	0.03	9.85	Upgrade
Change in Net Working Capital	230.8	-1.12	0.14	-0.7	4.69	-4.49	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.